These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20599264)

  • 21. Is dapsone safe?
    Pettit JH
    Int J Dermatol; 1981 Mar; 20(2):106-7. PubMed ID: 7216589
    [No Abstract]   [Full Text] [Related]  

  • 22. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
    Simpson JA; Hughes D; Manyando C; Bojang K; Aarons L; Winstanley P; Edwards G; Watkins WA; Ward S
    Br J Clin Pharmacol; 2006 Mar; 61(3):289-300. PubMed ID: 16487222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and identification of a degradant in chlorproguanil-dapsone-artesunate (Dacart™) tablets.
    Bardsley B; Barry SJ; Drozdz MA; Hancock SA; Okafo GN; Szafran MM
    J Pharm Biomed Anal; 2011 Feb; 54(3):610-3. PubMed ID: 20970278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
    Brabin BJ; Eggelte TA; Parise M; Verhoeff F
    Drug Saf; 2004; 27(9):633-48. PubMed ID: 15230645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
    Eaton L
    BMJ; 2009 Oct; 339():b4167. PubMed ID: 19825970
    [No Abstract]   [Full Text] [Related]  

  • 26. Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
    Winstanley P; Watkins W; Muhia D; Szwandt S; Amukoye E; Marsh K
    Trans R Soc Trop Med Hyg; 1997; 91(3):322-7. PubMed ID: 9231209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic effect of Malarone against malaria: all good news?
    Nosten F
    Lancet; 2000 Dec; 356(9245):1864-5. PubMed ID: 11130375
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
    Onadeko BO; Bademosi O
    Ir J Med Sci; 1974 Jul; 143(4):208-13. PubMed ID: 4852166
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of acute drug-induced hemolytic anemia associated with glucoso-6-phosphate dehydrogenase deficiency].
    Dul'tsina SM; Matveev MP; Shatunova LV
    Vopr Okhr Materin Det; 1967 Feb; 12(2):81-4. PubMed ID: 5611382
    [No Abstract]   [Full Text] [Related]  

  • 30. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
    Luzzatto L; Seneca E
    Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G6PD gene mutations in India producing drug-induced haemolytic anaemia.
    Sukumar S; Colah R; Mohanty D
    Br J Haematol; 2002 Mar; 116(3):671-2. PubMed ID: 11849231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
    Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
    J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemolytic anemia in a child with malaria treated with arthemeter].
    Muñoz-Vilches MJ; Salas-Coronas J; Giménez-López MJ; Cabezas-Fernández MT
    Enferm Infecc Microbiol Clin; 2013 Mar; 31(3):192-3. PubMed ID: 23084606
    [No Abstract]   [Full Text] [Related]  

  • 37. Malarone-donation programme in Africa.
    Ringwald P; Basco LK
    Lancet; 1998 Feb; 351(9103):673-4. PubMed ID: 9500354
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
    Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
    BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
    [No Abstract]   [Full Text] [Related]  

  • 39. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil.
    Wielgo-Polanin R; Lagarce L; Gautron E; Diquet B; Lainé-Cessac P
    Int J Antimicrob Agents; 2005 Aug; 26(2):176-8. PubMed ID: 16009537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.